glp 1 court case Ozempic Lawsuit for Blindness, Stomach Paralysis and Injury Claims Weight loss drug lawsuit update

GLP-1 does not show confirmed cancer risk in humans

Mike Saltaformaggio is a passionate trial lawyer known for his unrelenting advocacy of his clients rights inside and outside the civil courtroom.

A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.

Semaglutide can accelerate fat loss, but without proper nutrition and supplementation, muscle tissue may decline alongside body weight

This clinically grounded guide walks you through the 10 most important lab questions to raise with your doctor before and during treatment.

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).